Position in AZN
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$2,527,634
+$315,221 QoQ
Shares Held
13,330
+18.8% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
#484
of 1,462 holders
Holding Since
Mar 2026
2 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in AZN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PICTON MAHONEY ASSET MANAGEMENT holds $130,004,533 across 10 Drug Manufacturers - General names. AZN ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
33,628 | $40,334,435 | |
| 2 | JNJ |
Johnson & Johnson
|
96,594 | $24,531,978 | |
| 3 | MRK |
Merck & Co., Inc.
|
176,844 | $22,724,454 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
119,118 | $15,049,368 | |
| 5 | BIIB |
Biogen Inc.
|
46,536 | $10,054,568 | |
| 6 | OGN |
Organon & Co.
|
575,000 | $7,785,500 | |
| 7 | ABBV |
AbbVie Inc.
|
25,497 | $6,416,065 | |
| 8 | AZN |
Astrazeneca PLC
This page
|
13,330 | $2,527,634 |
All Filings in AZN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,527,634 | 13,330 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $2,212,413 | 11,218 | Shares | Sole | 2026-05-13 | |
| No filing history on record for this holder in this stock. | ||||||